Andrew Oxtoby

Chief Commercial Officer, Aimmune Therapeutics (United Kingdom).

Companies

Kalaris Therapeutics, Inc.Board member Mar 18, 2025 to now¹
Kalaris Therapeutics, Inc.Officer Mar 18, 2025 to now¹
CHINOOK THERAPEUTICS, INC.Chief Commercial Officer Feb 16, 2023 to Aug 11, 2023²
Aimmune Therapeutics (United Kingdom)Chief Commercial Officer Jan 24, 2019 to Oct 14, 2020³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKalaris Therapeutics, Inc., Board member
2
SEC EDGARCHINOOK THERAPEUTICS, INC., Chief Commercial Officer
3
SEC EDGARAimmune Therapeutics (United Kingdom), Chief Commercial Officer